New patient mobility allows piecemeal capital investments around the EU
This article was originally published in Clinica
Executive Summary
Patient mobility comes at a high cost to the smaller countries of the EU, which send their patients to neighbouring countries for treatment due to the lack of availability of services or technology at home. It has the effect of diverting healthcare funds - often to countries with high fees - and this inevitably delays the introduction of new technologies and treatments in the home country.
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: